Category: Funding

Funding

Tune Therapeutics launches with $40M in funding, aims to fine-tune activity of genes in cells

• Posted onDecember 6, 2021 Last Updated: December 6, 2021
• By: Kaitlyn Grosse

Funding

Cell Therapy Startup Immusoft Lands Deal With Takeda Worth Potentially More Than $900M

• Posted onOctober 18, 2021 Last Updated: October 18, 2021
• By: Kaitlyn Grosse

Funding

Seattle Biotech Alpine Immune Sciences Raises $91M for Drug Development

• Posted onSeptember 20, 2021 Last Updated: September 20, 2021
• By: Kaitlyn Grosse

Funding

Startup A-Alpha Bio Sets Out To Solve A Major Protein Problem Facing Big Pharma

• Posted onSeptember 13, 2021 Last Updated: September 13, 2021
• By: Kaitlyn Grosse

Funding

Life-Sciences Investment Volume Hit $9B in First Half of 2021, Tracking To a Record Year for CRE Sector

• Posted onSeptember 7, 2021 Last Updated: September 7, 2021
• By: Kaitlyn Grosse

Funding

Biotech Companies Fuel IPO Boom in Washington State Over the Past Year

• Posted onAugust 30, 2021 Last Updated: August 30, 2021
• By: Kaitlyn Grosse

Funding

In Washington’s Life Sciences Sector, A Streak of Companies Going Public

• Posted onAugust 9, 2021 Last Updated: August 9, 2021
• By: Kaitlyn Grosse

Funding

Icosavax Stock Skyrockets 200% on First Day of Trading for Newly Public Seattle Biotech Company

• Posted onAugust 2, 2021 Last Updated: August 2, 2021
• By: Kaitlyn Grosse

Funding

Absci Shares Spike 30% in IPO Debut, Valuing Washington State Biotech Company at Nearly $2B

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Grosse

Funding

Eliem Therapeutics Files for IPO as Another Seattle-Area Biotech Firm Set to Go Public

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Grosse